Biocon Limited, India's second largest biotechnology company, has posted an almost three times increase in net profit to Rs 80.8 crore for the quarter ending on December 31,2009 against Rs 28.2 crore for the quarter ending on December 31, 2008.
Net sales has gone up by 45 per cent to Rs 635 crore for quarter ended December 31, 2009 against Rs 436 crore in the same the quarter last year.
Biocon has said that there was robust sales of APIs (active pharmaceutical ingredients) in developed markets, healthy uptake in insulin sales in India and emerging markets, backed by 37 per cent growth in branded formulations.
Content Guide
